Clinical Trial Update: The PK/PD Study of Single Dose of SHR3824 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 PK/PD study of a single dose of SHR3824 in healthy volunteers has been completed, evaluating pharmacokinetics and pharmacodynamics in the context of Typ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SHR3824

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED